Research Signal – Source date 2025-09-25
Burning, shooting pain, tingling, or pain from a light touch can continue after the injury that began it has healed. Neuropathic pain can also combine unusual sensitivity with numbness or reduced sensation in the same area. These symptoms reflect more than a simple readout of ongoing tissue damage: damaged nerves can keep firing, while the circuits that process their messages can become more excitable.
A review published on 25 September 2025 brings several possible contributors together: oxidative stress, inflammation, mitochondrial dysfunction, and cellular senescence. Its proposed account is that oxidants can push cells into lasting stress responses, some of which release inflammatory signals; those signals can, in turn, sustain activity in nerves and pain-processing circuits. The review synthesizes research across cells and pain models. It is a mechanistic explanation, not a new patient experiment.
Peripheral nerves can become easier to trigger
After nerve damage, immune cells gather around the injured area alongside resident cells such as Schwann cells. These cells release inflammatory signals and reactive oxygen and nitrogen species, chemically reactive molecules that can alter how nearby nerves behave. In the review’s account, this local response can lower the activation threshold of pain-sensing nerve cells and promote abnormal, continuing activity.
Oxidants can also affect the channels that control electrical signals in those nerves. The review describes oxidation products that can sensitize TRPV1, a channel involved in responses to heat and chemical stimuli, and modify TRPA1, which also responds to irritants. Changes to sodium, potassium, and HCN channels may make repetitive or ectopic firing more likely. In practical terms, the injured nerve may send more frequent messages, or respond to inputs that would not normally provoke the same signal.
Mitochondria add another part of the explanation. These structures supply much of the energy neurons need to restore their electrical balance after firing and to manage calcium inside the cell. If mitochondria in a long sensory nerve fiber are impaired, energy supply and calcium regulation can falter, making spontaneous discharges more likely. More signals arriving from the periphery give the spinal cord a stronger stream of input to process.
Spinal circuits can lose some of their braking power
Persistent incoming signals are only part of the story. In the spinal dorsal horn, the first major processing station for many pain messages, immune and glial cells can change how strongly incoming activity is passed along. Microglia respond to injury-related cues and redox imbalance. The review describes microglial pathways that release inflammatory mediators, including interleukin-1 beta and brain-derived neurotrophic factor, or BDNF.
BDNF can reduce the amount of KCC2, a transporter that helps nerve cells maintain the conditions needed for inhibition. With less KCC2, signals carried by GABA and glycine become less effective at restraining activity in spinal neurons. The result can be a shift in the balance of the circuit: incoming signals are more likely to be amplified rather than damped. This is one route to central sensitization, in which the nervous system responds more strongly to stimulation.
Astrocytes can help maintain this altered environment. The review describes reactive astrocytes producing inflammatory signals and prostaglandins through COX-2, while changes in their normal support functions can affect the handling of glutamate and potassium. Microglia and astrocytes are different cell types with distinct roles, but their signals can interact. Together, these changes may help sustain heightened spinal activity after the original injury.
Senescence can change a cell’s long-term behavior
Cellular senescence is a lasting state in which a cell stops dividing while remaining metabolically active. In dividing cells, stress or DNA damage can trigger pathways involving p53 and the cell-cycle regulators p16 and p21, which help enforce that arrest. Senescent cells can also produce a collection of inflammatory and tissue-modifying substances known as the senescence-associated secretory phenotype, or SASP. In some settings, these secretions contribute to repair; when they persist, they may keep inflammation active.
Many neurons do not divide, so classical growth arrest cannot describe senescence in them in the same way it describes senescence in dividing cells. The review discusses senescence-like features reported in neurons and glia, including p16 or p21, signs of persistent DNA damage, and inflammatory secretions. These markers point to a stress-associated cell state, but they do not by themselves show that the marked cells are driving pain, or that the same process matters equally across different causes of neuropathy.
The context matters because stress responses can have protective roles. Senescence can limit harmful cell-cycle re-entry, and secreted signals may contribute to wound healing or remodeling. A response that helps contain damage in one setting could become harmful if it persists or spreads inflammatory signaling. The review’s central proposal is that persistent redox stress, senescence-associated signaling, and neuroinflammation may reinforce one another, but the balance and consequences may differ by cell type and stage of disease.
Mitochondrial health and Nrf2 connect several mechanisms
Mitochondria are not simply energy suppliers. Cells continually adjust their shape, replace damaged mitochondria, and remove those that no longer work properly. The review describes how disrupted mitochondrial maintenance can leave nerve cells with damaged, oxidant-producing mitochondria, adding stress while reducing the energy available for normal signaling. This offers a possible link between persistent oxidative stress and continuing nerve excitability.
The review presents Nrf2 as a coordinator of cellular defenses. Nrf2 can regulate genes involved in antioxidant responses, mitochondrial function, and inflammatory control. In experimental pain models discussed by the review, activating Nrf2-related defenses is associated with reduced neuropathic pain behaviors. Those findings make Nrf2 a candidate for further study; they do not demonstrate that an Nrf2-directed treatment relieves pain safely or durably in people.
Several uncertainties shape how this proposal should be interpreted. The review brings evidence from different cell types, causes of neuropathic pain, and experimental models into one account, so a mechanism observed in one context may not be decisive in another. Senescence-like markers do not establish which cells, if any, are maintaining a particular person’s pain. The review’s proposed combination of redox support, mitochondrial support, senescence control, and neuroimmune regulation is a research direction, not an established clinical regimen. Direct evidence of patient benefit and safety would be needed before those approaches could guide care.
Toward more durable relief from nerve pain
For people living with persistent neuropathic pain, a more precise understanding of which cellular processes are active could eventually help identify treatments that ease pain more durably and improve function. That possibility depends on reliably identifying the relevant mechanisms in people, then demonstrating that mechanism-matched approaches are safe and beneficial. The 2025 review offers a way to connect several lines of biological research; it does not yet show that targeting senescence or Nrf2 achieves that outcome.
Key Sources
- Primary source: Oxidative Stress, Inflammation, and Cellular Senescence in Neuropathic Pain: Mechanistic Crosstalk.
DOI or Journal Page · Review or Meta-Analysis · 2025-09-25
Keep exploring